India Cystoscopy and Ureteroscopy Market Size and Forecast 2021-2031, Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Procedure, Technology, Usage Type, and End User

Description

List of Tables

The India cystoscopy and ureteroscopy market expected to grow from US$ 180.00 million in 2023 to US$ 313.63 million by 2031; it is estimated to register a CAGR of 7.2% from 2023 to 2031. Factors such as increasing prevalence of urological diseases, and development of technologically advanced and minimally invasive products are the key factors driving the India cystoscopy and ureteroscopy market growth.

Cystoscopy and ureteroscopy are medical procedures used to examine and treat conditions of the urinary tract focusing on different areas of the urinary system. Cystoscope and ureteroscope are thin flexible and rigid tube with light and camera attached to it which helps in visualization of the interior of bladder and urethra for treatment and diagnosis of urinary disorders.

India has emerged as one of the most popular medical tourism destinations in the world, particularly for the diagnoses and treatments of urological conditions. The country's healthcare system is renowned for its high-quality services at a fraction of the costs incurred in Western countries. International patients, particularly from regions such as the Middle East, Africa, and Southeast Asia, are increasingly choosing India for their medical treatments due to the affordability, quality of care, and availability of advanced medical technology. As per the India Tourism Statistics 2023, in 2022, there were 6.43 million Foreign Tourist Arrivals (FTAs) in India; 7.4% of these FTAs traveled for medical purposes. The Government of India recognizes the potential of medical tourism, and it has introduced various initiatives to promote its growth. These initiatives include the issuance of medical visas for foreign patients, partnerships with international hospitals, and the establishment of dedicated medical tourism facilitation centers. In 2024, the government launched an initiative called Heal in India as an effort to further boost its medical tourism. The Ministry of Health and Family Welfare, the Government of India, and the Ministry of Ayush have been collaborating with the Centre for Development of Advanced Computing and the Services Export Promotion Council to propel this initiative through the "One Step Heal" portal. Additionally, many top-tier Indian hospitals and healthcare institutions are accredited by international organizations such as the Joint Commission International (JCI), further enhancing the country's reputation as a healthcare hub.

Cystoscopy and ureteroscopy are among the most sought-after procedures by medical tourists seeking treatment for urological conditions such as kidney stones, bladder cancer, and prostate problems. The availability of state-of-the-art equipment and skilled urologists also makes the country an attractive destination for these procedures. Thus, as medical tourism continues to grow, the demand for cystoscopy and ureteroscopy is expected to rise, providing significant opportunities for healthcare providers and medical equipment manufacturers to expand their reach. Additionally, the flourishing medical tourism encourages hospitals and clinics to upgrade their infrastructure and equipment to cater to international patients. Thus, India's focus on strengthening its position as a global leader in medical tourism generates significant growth opportunities for the India cystoscopy and ureteroscopy market in the near future.

The India cystoscopy and ureteroscopy market is categorized into product type, procedure, technology, usage type, and end user. Based on product type, the India cystoscopy and ureteroscopy market is segmented into cystoscope, ureteroscope, and urology camera. The cystoscope segment accounted for the largest India cystoscopy and ureteroscopy market share in 2023. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period. Cystoscopes are essential tools for examining the bladder and urinary tract, and these instruments have undergone significant technological advancements in recent years. Modern cystoscopes feature high-definition imaging, 3D visualization, and fluorescence technologies, which enhance their diagnostic precision. Moreover, innovations such as flexible, miniaturized designs and improved light sources contribute to better access to hard-to-reach areas along with greater patient comfort. Additionally, the integration of artificial intelligence aids in the early detection of abnormalities, further improving diagnostic accuracy.

Based on procedure, the India cystoscopy and ureteroscopy market is segmented into benign prostrate hyperplasia (BPH), bladder cancer, stone management, and others. The stone management segment accounted for the largest India cystoscopy and ureteroscopy market share in 2023.

Based on technology, the India cystoscopy and ureteroscopy market is segmented into fiber optic, video, and others. The video segment accounted for the largest share of the total India cystoscopy and ureteroscopy market size in 2023.

Based on usage type, the India cystoscopy and ureteroscopy market is bifurcated into reusable and single use. The reusable segment accounted for a larger share of the market in 2023. However, the single use segment is anticipated to register a higher CAGR in the market during the forecast period.

Based on end user, the India cystoscopy and ureteroscopy market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. The hospitals segment accounted for the largest share of the market in 2023, and same segment is anticipated to register the highest CAGR in the market during the forecast period.

The Food and Drug Administration, Central Drugs Standard Control Organisation (CDSCO), Federal Transit Administration (FTA), Transit Cooperative Research Program, and Centers for Disease Control and Prevention (CDC) are among the primary and secondary sources referred to while preparing the India cystoscopy and ureteroscopy market report.

Product Code: TIPRE00039396

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. India Cystoscopy and Ureteroscopy Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Pricing Analysis

5. India Cystoscopy and Ureteroscopy Market - Key Market Dynamics

5.1 India Cystoscopy and Ureteroscopy Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Urological Diseases
- 5.2.2 Development of Technologically Advanced and Minimally Invasive Products
5.3 Market Restraints
- 5.3.1 High Cost of Equipment and Procedures
5.4 Market Opportunities
- 5.4.1 Growing Medical Tourism Industry
5.5 Future Trends
- 5.5.1 Shift Toward Robotic-Assisted Urological Surgeries
5.6 Impact of Drivers and Restraints:

6. India Cystoscopy and Ureteroscopy Market Analysis

6.1 India Cystoscopy and Ureteroscopy Market Revenue (US$ Million), 2021-2031

7. India Cystoscopy and Ureteroscopy Market Analysis - by Product Type

7.1 Cystoscope
- 7.1.1 Overview
- 7.1.2 Cystoscope: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Ureteroscope
- 7.2.1 Overview
- 7.2.2 Ureteroscope: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Urology Camera
- 7.3.1 Overview
- 7.3.2 Urology Camera: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)

8. India Cystoscopy and Ureteroscopy Market Analysis - by Procedures

8.1 Stone Management
- 8.1.1 Overview
- 8.1.2 Stone Management: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Bladder Cancer
- 8.2.1 Overview
- 8.2.2 Bladder Cancer: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Benign Prostrate Hyperplasia (BPH)
- 8.3.1 Overview
- 8.3.2 Benign Prostrate Hyperplasia (BPH): India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)

9. India Cystoscopy and Ureteroscopy Market Analysis - by Technology

9.1 Fiber Optic
- 9.1.1 Overview
- 9.1.2 Fiber Optic: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Video
- 9.2.1 Overview
- 9.2.2 Video: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)

10. India Cystoscopy and Ureteroscopy Market Analysis - by Usage Type

10.1 Reusable
- 10.1.1 Overview
- 10.1.2 Reusable: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Single Use
- 10.2.1 Overview
- 10.2.2 Single Use: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)

11. India Cystoscopy and Ureteroscopy Market Analysis - by End User

11.1 Hospitals
- 11.1.1 Overview
- 11.1.2 Hospitals: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Ambulatory Surgical Centers
- 11.2.1 Overview
- 11.2.2 Ambulatory Surgical Centers: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Specialty Centers
- 11.3.1 Overview
- 11.3.2 Specialty Centers: India Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)

12. Company Profiles

12.1 Olympus Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Karl Storz SE & Co KG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Richard Wolf GmbH.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Ambu A/S
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 PENTAX Medical
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Advin Health Care Pvt Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Coloplast Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Cook Medical Holdings LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Electronics Services Centre (ESC Medicams)
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Stryker Corp
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Rudra Surgicals
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Laborie
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Teleflex Inc
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 NIDHI MEDITECH SYSTEMS
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Pioneer Healthcare Technologies
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
12.16 Boston Scientific Corp
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 Ottomed Endoscopy
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments
12.18 Becton Dickinson and Co
- 12.18.1 Key Facts
- 12.18.2 Business Description
- 12.18.3 Products and Services
- 12.18.4 Financial Overview
- 12.18.5 SWOT Analysis
- 12.18.6 Key Developments
12.19 SCHOLLY FIBEROPTIC GMBH
- 12.19.1 Key Facts
- 12.19.2 Business Description
- 12.19.3 Products and Services
- 12.19.4 Financial Overview
- 12.19.5 SWOT Analysis
- 12.19.6 Key Developments
12.20 MicroPort Scientific Corp
- 12.20.1 Key Facts
- 12.20.2 Business Description
- 12.20.3 Products and Services
- 12.20.4 Financial Overview
- 12.20.5 SWOT Analysis
- 12.20.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms